South Delhi Pharma, New Delhi, India
PREZISTA (darunavir) Oral Suspension, for Oral use.
Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email query@southdelhipharma.com to discuss.
PREZISTA is a prescription medicine. PREZISTA is used for HIV infection Treatment.
INDICATIONS AND USAGE
PREZISTA is a human immunodeficiency virus (HIV-1) protease inhibitor indicated for the treatment of HIV-1 infection in adult patients. PREZISTA is also indicated for the treatment of HIV-1 infection in pediatric patients 3 years of age and older. PREZISTA must be co-administered with ritonavir (PREZISTA/ritonavir) and
with other antiretroviral agents.
DOSAGE FORMS & STRENGTHS
• 100 mg/mL oral suspension
• 75 mg tablets, 15
Manufactured By: Janssen Products, LP
Prescribing Information URL: Click Here
South Delhi Pharma can facilitate the supply of “PREZISTA (darunavir) Oral Suspension” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
Contact Number:
M:+91-9891296838 / P:+91-11- 26532129
Email ID:
info@southdelhipharma.com
Darunavir (DRV), sold under the brand name Prezista among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It is often used with low doses of ritonavir or cobicistat to increase darunavir levels. It may be used for prevention after a needlestick injury or other potential exposure. It is taken by mouth once to twice a day.
Darunavir was approved for medical use in the United States in 2006 and in the European Union in February 2007. It is on the World Health Organization's List of Essential Medicines. The fixed-dose combination medication darunavir/cobicistat (Rezolsta) is available as a single pill.
